.
1332 financial statements
* Numbers in millions
Year |
2020 | TTM |
|---|---|---|
Capitalization * |
3 982 | 2 539 |
EV * |
4 062 | 4 062 |
Stock price ¤ |
1.49 | 0.95 |
Number of shares * |
2 672 | 2 672 |
EPS |
-0,06 | -0,06 |
Revenue * |
207 | 207 |
Net income * |
-169 | -169 |
Operating profit * |
-52 | -52 |
Total liabilities * |
416 | 416 |
Net debt * |
80 | 80 |
Total assets * |
972 | 972 |
Equity * |
556 | 556 |
Cash and investments * |
254 | 254 |
Over the past 10 years, the maximum capitalization of Touyun Biotech Group Limited is 3 982, the minimum is 3 982. Maximum net income 0, Minimum net income -169. The maximum price of 1332 shares is 1.49, the minimum price is 1.49.
.
1332 valuation
Year |
2020 | TTM |
|---|---|---|
P/E |
-23,59 | -15,04 |
P/B |
7,16 | 4,56 |
P/S |
19,26 | 12,28 |
E/P |
-4% | -7% |
P/FCF |
-28,27 | -18,02 |
.
1332 profitability
Year |
2020 | TTM |
|---|---|---|
ROE |
-30% | |
ROA |
-18% | |
ROIC |
-9% |